Coronavirus: UK approves Moderna vaccine and to impose negative test for travellers, BioNTech/Pfizer


In coronavirus news this Friday, the UK has approved the vaccine developed by Moderna Therapeutics Inc (NASDAQ:MRNA) but because of Brexit deliveries will not arrive before April.

London has ordered 7mln doses of the jab, already approved in the EU, which has secured 160mln doses, and the US.

According to an analysis carried out for the Guardian, vaccinations need to double each week over the next fortnight to reach the government’s target to immunize all 13.9mln vulnerable people by mid-February.

The Moderna vaccine, the third approved in the UK, will not help towards this goal.

So far, 1.3mln people in the UK have received the first dose of the BioNTech/Pfizer Inc (NYSE:PFI) or the Oxford/AstraZeneca PLC (LON:AZN) jabs and 21,000 the booster dose.

Mandatory negative tests at the border

England and Scotland have joined many other countries in requiring a negative COVID-19 test result for inbound travellers.

All international arrivals, including UK nationals, will be required to take the assay up to 72 hours prior to departure.

Passengers be subject to an immediate fine of £500 if they fail to comply, while the 10-day quarantine is still mandatory unless people are coming from countries on the government’s travel corridor list.

England will implement the measure as early as next week.

Good for variation

The BioNTech/Pfizer inoculation may be effective against the new virus variants found in the UK and South Africa, according to a study by the University of Texas Medical Branch and supported by the two companies.

Researchers tested antibodies in the blood of people who received the jab against a lab-created version of the new strain.

–Adds Moderna vaccine approval news–


Please enter your comment!
Please enter your name here